|
Volumn 7, Issue 11, 2001, Pages 1093-1100
|
Effect of prescription benefit changes on medical care utilization in a Medicare HMO population
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GENERIC DRUG;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
AGE;
AGED;
ANALYTIC METHOD;
ARTICLE;
COHORT ANALYSIS;
COMORBIDITY;
COMPARATIVE STUDY;
CONSULTATION;
CONTROLLED STUDY;
COST CONTROL;
DRUG COST;
FEMALE;
FOLLOW UP;
GERIATRIC PATIENT;
HEALTH CARE AVAILABILITY;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH CARE UTILIZATION;
HEALTH INSURANCE;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICARE;
MULTIVARIATE ANALYSIS;
PREDICTION;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
AGED;
COHORT STUDIES;
COST SHARING;
HEALTH MAINTENANCE ORGANIZATIONS;
HEALTH SERVICES FOR THE AGED;
HEALTH SERVICES RESEARCH;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
MEDICARE;
ORGANIZATIONAL POLICY;
SOUTHEASTERN UNITED STATES;
UNITED STATES;
|
EID: 0035186808
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (27)
|
References (15)
|